Analysis

UK

Is the US election likely to challenge pharma and biotech sentiment further?

The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.

clock 20 April 2016 • 2 min read

Asia

How can Japan deal with its overwhelming public debt issue?

Recovery in domestic economy

clock 19 April 2016 • 2 min read

Europe

The success of German 'Mittelstand'

Focus on highly successful SME businesses

clock 19 April 2016 • 2 min read

Equities

US company outlook not consistent with 'imminent US recession' forecasts

Stronger than 2015

clock 19 April 2016 • 2 min read

Specialist

Can tech groups sustain their growth as US and China slow down?

Tech not immune from growth concerns

clock 19 April 2016 • 2 min read

Emerging markets

Why the EM definition will have changed completely in five years

Gap in GDP growth between India and Brazil increases

clock 19 April 2016 • 2 min read

Commodities

Guinness AM: Sentiment hit but oil market is rebalancing without Doha

Significant meeting means limited oil price downside

clock 18 April 2016 • 4 min read

Global

How are strategic bond managers positioned for 2016?

Morgan Stanley and Baillie Gifford discuss

clock 18 April 2016 • 5 min read

Regulation

MiFID II: How the delegated acts will impact product governance

Rob Swan, managing director - data services at Calastone Data Services, examines the implications of the latest set of European regulations for fund managers.

clock 18 April 2016 • 6 min read

Technology

The 'ferociously competitive internet giants' driving China's tech revolution

Baidu, Alibaba and Tencent

clock 18 April 2016 • 4 min read
Trustpilot